Maximum quantity allowed is 999
Please select the quantity
CAS RN: 745-65-3 | Product Number: P1917
Prostaglandin E1
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- Alprostadil
- PGE1
- (11α,13E,15S)-11,15-Dihydroxy-9-oxoprosta-13-en-1-oic Acid
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time | Quantity |
Shipping Information
|
|---|---|---|---|---|---|---|
| 10MG |
S$274.50
|
6 | 1 | It can be shipped in about 2 weeks after ordering |
|
* Please contact our distributors or
TCI
to order TCI products.
* The storage conditions are subject to change without notice.
| Product Number | P1917 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__0H__3__4O__5 = 354.49 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 745-65-3 |
| Reaxys Registry Number | 2061617 |
| PubChem Substance ID | 468592574 |
| Merck Index (14) | 7875 |
| MDL Number | MFCD00077860 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 115.0 to 119.0 °C |
| Specific rotation | -64.0 to -68.0 deg(C=0.2,ethanol) |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 116 °C |
| Maximum Absorption Wavelength | 278(EtOH) nm |
GHS
| Pictogram |
|
| Signal Word | Danger |
| Hazard Statements | H301 : Toxic if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
Related Laws:
| RTECS# | GY4569800 |
Transport Information:
| UN Number | UN2811 |
| Class | 6.1 |
| Packing Group | III |
| H.S.code* | 2937.50-000 |
Application
Prostaglandin E1: A Naturally Occurring Prostaglandin with Vasodilation and Anti-Platelet Aggregating Effects
Prostaglandin E1 (PGE1) is produced by the theoretical metabolism of dihomo-y-linolenic acid (DGLA) [E0640] by the cyclooxygenase pathway.1) It has been reported that PGE1 has many pharmacological activities, such as vasodilation, anti-inflammatory, anti-platelet aggregation, protection of vascular endothelial cells, prevention of atherosclerosis, and so on.2) PGE1 is known to improve fluidity of blood through its vasodilation and anti-platelet aggregating effects. (The product is for research purpose only.)
References
- 1) Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction
- 2) The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience (a review)
Articles/Brochures
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.